Statement by Mr. Nicolas Sarkozy, President of the Republic, on the fight against Alzheimer's disease and related diseases within the European framework, in Paris on October 31, 2008.

France Nicolas Sarkozy · President of France

31 October 2008 · European conference on the fight against Alzheimer's disease and related disorders · Paris, France

Context
Sarkozy addressed a European conference on Alzheimer's disease in Paris on October 31, 2008, presenting France's national plan and calling for EU-wide action.
Main themes
Alzheimer's disease, French Alzheimer Plan 2008-2012, European cooperation on health, research and innovation, care and support for patients, solidarity and social values, public-private partnerships in research, diagnosis and early detection, aging populations, family and caregiver support, European Charter of Fundamental Rights, funding and resources for healthcare
Duration
~22 min
70th percentile
Words
2,641
70th percentile
Sentences
162
83rd percentile
Readability
46
52nd percentile
Grade
10.8
30th percentile
Syntax
2.66
10th percentile
Vocabulary
2.20
49th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 56%54%
  • Institutional 18%17%
  • Geopolitical 11%10%
  • Ceremonial 8%8%
  • Technological 5%5%
  • Economic 2%2%
  • Environmental 0%0%
  • Not in focus 4%

162 sentences in 48 paragraphs

Ladies and Gentlemen Ministers,

Madam Commissioner,

Ladies and Gentlemen Parliamentarians,

My dear friends,

France is pleased to host the European conference on the fight against Alzheimer's disease and related disorders. You are all, in various capacities, the actors in this fight in Europe: patients and families, policymakers, local elected officials, parliamentarians, experts, leaders of associations and foundations, researchers, doctors, and care professionals. I commend your commitment to this battle. I want to pay tribute to this commitment, across Europe, alongside the women and men who suffer from slowly fading away, from no longer knowing who they are, from no longer feeling the love of their family. Therefore, I want to honor you who are on the front lines of this fight, you who, due to the whims of existence or a foresight that honors you, have made the fight against Alzheimer's disease the battle of your life.

I have decided to make the fight against this scourge a priority of my term as President of the French Republic. Allow me to say a few words about it. Last February 1st, together with the relevant ministers, we announced the launch of the Alzheimer Plan for the period 2008-2012. This is not the first Plan that our country has known. But it is the first, I believe, that develops a comprehensive approach to the disease by deploying significant resources - 1.6 billion euros in new spending over five years.

I wanted to engage personally. Because our country has several hundred thousand sick people. Because this number will inevitably increase in the coming years. Because almost all families are affected. And because, together with the ministers, we want to refuse fatalism.

I made this choice in the name of the values that are mine. I think of the respect owed to our elders. I think of solidarity towards the most vulnerable. I think of the role of the family. I think of the cohesion of our societies.

But do I need to justify my choice before you? I suppose you are the first to be convinced of it.

The hallmark of the French Alzheimer Plan is to integrate research, care, and support, hence the presence of Roselyne BACHELOT, Valérie PÉCRESSE, and Valérie LETARD. Together, we have proposed a coherent plan. Our goal is not only to intensify our efforts in each of these areas taken separately. Our goal is to develop synergies to improve the quality of life of patients and their loved ones.

Research is the first component of the Alzheimer Plan. We want to intensify our research efforts. Excellent research is the condition for quality care and support. I wanted our research efforts to be coordinated by a foundation that also gives a significant place to public-private partnerships. We cannot afford to deprive ourselves of part of the research.

The second component of the Alzheimer Plan is to strengthen our diagnostic and care capacities. The announcement of the disease is an essential measure. We want to integrate diagnosis and care so that the announcement of the diagnosis does not leave the patient and their family alone in the face of the disease.

Support is the last component of the Plan. It is the role of the care and integration homes for Alzheimer's patients, the first of which will be experimented with in 2009. Home care will be prioritized with the help of new technologies. And nursing homes will need to develop, thanks to increased staffing, specific care based particularly on research in social sciences.

But our action cannot remain confined to the national level. I wish, and I announced it alongside President BARROSO on July 1st, to bring the fight against Alzheimer's disease to the European level. This is crucial.

This fight must be that of all of Europe. Because all member states are concerned. There are several million sick people in Europe. Due to longevity, their number will increase. It seems to me that Europe must resolutely engage in the fight against Alzheimer's disease because it is a matter of European values.

The Charter of Fundamental Rights of the European Union reminds us of our duty to preserve the dignity of sick individuals; this is an absolute imperative.

Solidarity is another founding value of Europe. Our systems of solidarity, despite their differences in organization, all call upon the state, social partners, businesses, or individual responsibility to protect our fellow citizens from the uncertainties of existence.

We want to make Europe a knowledge and innovation society. The fight against Alzheimer's disease must be a priority area of application for this strategy. Aging Europe must do everything possible to better understand Alzheimer's disease and its effects on the lives of 500 million Europeans. Europe must put its research and innovation capabilities to work for the discovery of reliable diagnostics and treatments.

The United States began to mobilize in the late 1970s. They created a dedicated research agency, the National Institute on Aging. Why should Europe succumb to fatalism? It is time for Europe to catch up and be at the forefront of global research on Alzheimer's disease.

The stakes are nothing less than the future of European civilization. The European Union was primarily created to protect. This protection of Europeans must be based on concrete projects. The fight against Alzheimer's disease must be an opportunity to illustrate this desire for protection for Europe.

I am convinced that Europe can add value in the fight against this scourge. Europe can do infinitely better than member states when they act separately.

Europe can promote a better understanding of the disease and greater coordination of excellent research.

Europe can facilitate the sharing of experiences, the development of common principles regarding the quality of care for patients and their caregivers.

Europe can develop an ethics of care that is based on our values.

Europe can act, it seems to me, along three axes: knowledge of the disease and research, sharing experiences on care and support, and ethics. I wish for the European Council to adopt, by the end of the French presidency, recommendations inviting each member state to establish an Alzheimer plan by 2010. This should be a sort of European "toolbox," from which each member state can draw according to its specificities and, of course, in respect of the principle of subsidiarity. Actions will differ from one country to another, but the priorities will be common. The comprehensive approach, both scientific, medical, and social, deserves to be shared by all because, in the end, it unites us all.

The pursuit of excellence in research is undoubtedly the area where the added value of the European Union can be the strongest. Access to knowledge is a prerequisite for overcoming our fears. Each country should have precise epidemiological data to better understand the spread of Alzheimer's disease and related disorders. We must know each year and in each country the number of sick individuals and the number of newly diagnosed individuals each year.

I add that Europe can allow us to study larger populations of sick individuals than those of each country taken in isolation. I am particularly thinking of young Alzheimer's patients. We could gain much finer knowledge of the disease and its evolution from these large European studies.

Europe must also make room for Alzheimer's disease in the research efforts conducted by each country. This disease struggles to be recognized as it should be in research programs. This situation was the case in France, and the Alzheimer plan specifically aims to bridge the gap compared to other research on the central nervous system, particularly regarding Parkinson's disease.

Today in Europe, less than 5% of research funds allocated to cancers are dedicated to Alzheimer's disease. Yet, there is an urgent need to better understand its mechanisms.

We must react. The European research area must translate into facilitated circulation of ideas and researchers; Europe needs concrete results.

I propose that member states establish, by 2010 at the latest, a coordinated programming of their research. Coordinated programming means better circulation of ideas and projects among Europeans. Coordinated programming means that member states must be able to agree to pool funding on a shared objective. This means more resources for common research projects rather than dispersed funding on national projects that ignore each other. The coordination of our research efforts must, of course, be based on voluntary participation. But greater coordination is essential to bring the European research area to life.

For coordination to make sense, we first need to have a comprehensive view of national research initiatives. The framework program for research and technological development must also strengthen its funding for Alzheimer's disease. The latter must be better taken into account in the upcoming calls for proposals of the seventh FP7. If we share a common vision on this fundamental issue for Europe, then we must be consistent and increase the European public research effort.

Europe must also promote the mobility of researchers. I would like "Alzheimer" scholarships to be offered to young researchers to work in other European countries. It is also necessary that states wishing to do so have the opportunity to create interdisciplinary collaboration networks between teams of different nationalities.

I am pleased that the "competitiveness" Council of September 26th understood that Alzheimer's disease is an additional necessity for building the European research area.

The second priority axis for Europe is the sharing of best practices in care and support.

Beyond these differences, there are appropriate care practices and others that are not. All member states will benefit from better understanding each other's practices. Together, we European states can develop a common foundation of recommendations to prevent Alzheimer's disease, to delay its onset, to define the role of the general practitioner in diagnosis, to organize the announcement, to provide follow-up, to implement effective therapies, and to support family caregivers. How can we help them? How can we coordinate the multitude of actors involved with the sick person?

We can attempt to answer these questions more effectively if we are not isolated. And rather than all asking the same questions while ignoring what others are doing, I believe we would do well to provide common answers to questions that are not specific but are instead posed in the same terms throughout Europe.

The EUROCODE project supported by the Commission must provide a rich database on the modes of care for the disease in Europe. Europe needs a greater number of concrete initiatives like this one for the fight against Alzheimer's disease to progress.

Beyond practices, we must share our reflections on the professions that need to be developed. Caring for sick individuals requires particular skills. We must make professions related to the aging population attractive. We must enhance the social role of these professions, their careers, and their remuneration. We are all faced with this challenge. We would benefit from providing common responses.

The third axis, finally, that I propose to you is that of ethical reflection. A common ethical reflection would be a wealth and would make the uniqueness of a united Europe. Because once again, the questions are the same for all Europeans: How to obtain the consent of a person for admission to a nursing home? How to reconcile respect for autonomy and the safety of the patient? How to act with a person who has lost their usual communication abilities? How to adapt care to the preferences of the person? What role can caregivers play in helping the patient express their choices?

These are concrete questions to which we must provide ethical answers. We cannot be satisfied, in the face of these questions, with simply technical responses. And we cannot be satisfied, dear Roselyne BACHELOT, with merely a compassionate response. I believe that between technique and compassion, there is a place for ethics. What are the values, what are the principles, what is the framework? Law can help us clarify certain situations. But what matters most is the behavior of each individual in the face of suffering and the gradual loss of the patient's autonomy. What is needed is a behavior that I would describe, Professor MENARD, as enlightened, a behavior that is based in all circumstances on the absolute respect for the dignity of the person. I know well that there are no universal rules in this matter. If the principle of respect for dignity is universal, its concrete application depends on the situation of the sick person, their surroundings, and their environment.

Europe could support the creation of a network allowing the exchange of best practices based on concrete cases encountered on the ground. The sharing of best practices among member states should help us better define what is, in the circumstances presented by Alzheimer's disease, the least bad attitude, for I doubt that there exists a good attitude in the face of the tragedy of this disease.

Ladies and Gentlemen,

I have proposed to you what the main lines of a resolute commitment from the European Union in the fight against Alzheimer's disease could be.

I am convinced that the Union can contribute significantly to this fight. I fully understand that subsidiarity does not make health a strictly European domain. But that is not a reason to do nothing. Subsidiarity is what entrusts states with the responsibility for what they can do better. But that does not mean that we should not engage in coordination. Just because health is not part of the corpus of the institutional competencies of Europe does not mean that the duty of researchers and policymakers, associations, and foundations is not to combine their knowledge to progress together, even if it means that each then makes the best application in their country of what they have observed as best practices elsewhere.

I believe we have a historic opportunity: to ensure that Europe demonstrates its ability to collectively face a challenge that wreaks havoc across all European peoples, Alzheimer's disease. I know well that in the financial and economic crisis we are experiencing, one might be surprised that the President of the Republic comes to speak about Alzheimer's disease. But Alzheimer's disease ignores the financial, monetary, and economic context. I mean that the suffering of a family may be further exacerbated by the context, certainly not alleviated. If we were to stop working on fundamental issues every time our world experiences a jolt or a crisis, then we would never do what is fundamental. And if I wanted to come before your conference, it is to clearly signify that during the crisis, the ravages of Alzheimer's disease continue. And it would be unacceptable to say that "we do not have time to take care of you, your suffering, your patients, your loved ones." It would be unacceptable. As if we should only take care of people's health when there is global growth and when there are no fiscal, monetary, financial, or economic problems. I therefore see in this crisis an opportunity, on the contrary, to do more. The news is entirely focused on finance, on monetary issues, and on the economy, but you do not work for the newspaper, you work for the book. You do not work for the daily, you work for the fundamental. You do not work for six months; you are engaged in a total fight against a scourge due to a progress of humanity: living longer, thus carrying with us diseases that make this life not quite a life anymore.

As President of the European Union, I want to say that regardless of the context I must also address, the fight of all Europeans against Alzheimer's disease is an absolute priority. We have made it a priority in France, and I wish for it to be a priority in Europe.

Ladies and Gentlemen, I thank you for accepting our invitation, and I thank you for the honor of listening to my remarks.